A Study of Varlilumab and IMA950 Vaccine Plus Poly-ICLC in Patients With WHO Grade II Low-Grade Glioma (LGG)

Clinical trial NCT02924038 · TERMINATED

Trial details

NCT number: NCT02924038
Sponsor: Nicholas Butowski
Status: TERMINATED
Phase: Phase 1
Study type: INTERVENTIONAL

Glioma Malignant Glioma Astrocytoma, Grade II Oligodendroglioma Glioma, Astrocytic Oligoastrocytoma, Mixed

Start date: 2017-04-03
Primary completion: 2022-12-31
Enrollment: 14

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.